2-(3,4-dihydroisoquinolin-2(1H)-yl)ethanamine,
53356-51-7,
2(1H)-Isoquinolineethanamine, 3,4-dihydro-,
NSC 159957,
BRN 1370770,
2(1H)-ISOQUINOLINEETHYLAMINE, 3,4-DIHYDRO-,
3,4-Dihydro-2(1H)-isoquinolineethylamine,
2-(3,4-dihydro-1H-isoquinolin-2-yl)ethanamine,
2-(1,2,3,4-Tetrahydro-2-isoquinoline)ethylamine,
MFCD01717314,
NSC159957,
AC1L24DP,
AC1Q54KL,
5-20-06-00335 (Beilstein Handbook Reference),
SCHEMBL335190,
CTK4J7726,
DTXSID60201516,
JTEJMGHPAYJBTA-UHFFFAOYSA-N,
ALBB-005368,
ANW-71710,
BBL037744,
STK503375,
ZINC19365196,
AKOS000140212,
MCULE-4676346334,
NSC-159957,
AJ-72935,
AM807253,
LS-85711,
3,4-Dihydro-2(1H)-isoquinolineethanamine,
2(1H)-Isoquinolineethanamine,3,4-dihydro-,
AB0049038,
TR-018872,
BB 0255254,
FT-0679104,
ST24039233,
V6454,
EN300-31281,
W-8581,
2-(3,4-dihydro-1H-isoquinolin-2-yl)ethylamine,
I05-1384,
J-505728,
2-(3,4-dihydroisoquinolin-2(1H)-yl)ethanamine, AldrichCPR,
C(CN)N1CCc2ccccc2C1,
C11H16N2,
CID40742,
C11-H16-N2,